Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Intervalo de ano de publicação
1.
Lancet Oncol ; 16(8): e405-13, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-26248848

RESUMO

Despite an estimated 456,000 deaths caused by cancer in sub-Saharan Africa in 2012 and a cancer burden that is predicted to double by 2030, the region accounts for only 0·3% of worldwide medical expenditure for cancer. Challenges to cancer care in sub-Saharan Africa include a shortage of clinicians and training programmes, weak healthcare infrastructure, and inadequate supplies. Since 2011, Rwanda has developed a national cancer programme by designing comprehensive, integrated frameworks of care, building local human resource capacity through partnerships, and delivering equitable, rights-based care. In the 2 years since the inauguration of Rwanda's first cancer centre, more than 2500 patients have been enrolled, including patients from every district in Rwanda. Based on Rwanda's national cancer programme development, we suggest principles that could guide other nations in the development of similar cancer programmes.


Assuntos
Prestação Integrada de Cuidados de Saúde/organização & administração , Países em Desenvolvimento , Política de Saúde , Oncologia/organização & administração , Neoplasias/terapia , População Negra , Comportamento Cooperativo , Prestação Integrada de Cuidados de Saúde/legislação & jurisprudência , Política de Saúde/legislação & jurisprudência , Necessidades e Demandas de Serviços de Saúde/organização & administração , Disparidades em Assistência à Saúde/organização & administração , Humanos , Oncologia/legislação & jurisprudência , Modelos Organizacionais , Neoplasias/diagnóstico , Neoplasias/etnologia , Neoplasias/mortalidade , Equipe de Assistência ao Paciente/organização & administração , Formulação de Políticas , Desenvolvimento de Programas , Avaliação de Programas e Projetos de Saúde , Ruanda/epidemiologia
2.
BMC Med ; 12: 6, 2014 Jan 14.
Artigo em Inglês | MEDLINE | ID: mdl-24423387

RESUMO

BACKGROUND: More than three decades after the 1978 Declaration of Alma-Ata enshrined the goal of 'health for all', high-quality primary care services remain undelivered to the great majority of the world's poor. This failure to effectively reach the most vulnerable populations has been, in part, a failure to develop and implement appropriate and effective primary care delivery models. This paper examines a root cause of these failures, namely that the inability to achieve clear and practical consensus around the scope and aims of primary care may be contributing to ongoing operational inertia. The present work also examines integrated models of care as a strategy to move beyond conceptual dissonance in primary care and toward implementation. Finally, this paper examines the strengths and weaknesses of a particular model, the World Health Organization's Integrated Management of Adolescent and Adult Illness (IMAI), and its potential as a guidepost toward improving the quality of primary care delivery in poor settings. DISCUSSION: Integration and integrated care may be an important approach in establishing a new paradigm of primary care delivery, though overall, current evidence is mixed. However, a number of successful specific examples illustrate the potential for clinical and service integration to positively impact patient care in primary care settings. One example deserving of further examination is the IMAI, developed by the World Health Organization as an operational model that integrates discrete vertical interventions into a comprehensive delivery system encompassing triage and screening, basic acute and chronic disease care, basic prevention and treatment services, and follow-up and referral guidelines. IMAI is an integrated model delivered at a single point-of-care using a standard approach to each patient based on the universal patient history and physical examination. The evidence base on IMAI is currently weak, but whether or not IMAI itself ultimately proves useful in advancing primary care delivery, it is these principles that should serve as the basis for developing a standard of integrated primary care delivery for adults and adolescents that can serve as the foundation for ongoing quality improvement. SUMMARY: As integrated primary care is the standard of care in the developed world, so too must we move toward implementing integrated models of primary care delivery in poorer settings. Models such as IMAI are an important first step in this evolution. A robust and sustained commitment to innovation, research and quality improvement will be required if integrated primary care delivery is to become a reality in developing world.


Assuntos
Efeitos Psicossociais da Doença , Prestação Integrada de Cuidados de Saúde/normas , Países em Desenvolvimento , Atenção Primária à Saúde/normas , Adolescente , Adulto , Atenção à Saúde/métodos , Atenção à Saúde/normas , Prestação Integrada de Cuidados de Saúde/métodos , Gerenciamento Clínico , Humanos
3.
BMC Health Serv Res ; 13 Suppl 2: S5, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23819573

RESUMO

BACKGROUND: Nationally, health in Rwanda has been improving since 2000, with considerable improvement since 2005. Despite improvements, rural areas continue to lag behind urban sectors with regard to key health outcomes. Partners In Health (PIH) has been supporting the Rwanda Ministry of Health (MOH) in two rural districts in Rwanda since 2005. Since 2009, the MOH and PIH have spearheaded a health systems strengthening (HSS) intervention in these districts as part of the Rwanda Population Health Implementation and Training (PHIT) Partnership. The partnership is guided by the belief that HSS interventions should be comprehensive, integrated, responsive to local conditions, and address health care access, cost, and quality. The PHIT Partnership represents a collaboration between the MOH and PIH, with support from the National University of Rwanda School of Public Health, the National Institute of Statistics, Harvard Medical School, and Brigham and Women's Hospital. DESCRIPTION OF INTERVENTION: The PHIT Partnership's health systems support aligns with the World Health Organization's six health systems building blocks. HSS activities focus across all levels of the health system - community, health center, hospital, and district leadership - to improve health care access, quality, delivery, and health outcomes. Interventions are concentrated on three main areas: targeted support for health facilities, quality improvement initiatives, and a strengthened network of community health workers. EVALUATION DESIGN: The impact of activities will be assessed using population-level outcomes data collected through oversampling of the demographic and health survey (DHS) in the intervention districts. The overall impact evaluation is complemented by an analysis of trends in facility health care utilization. A comprehensive costing project captures the total expenditures and financial inputs of the health care system to determine the cost of systems improvement. Targeted evaluations and operational research pieces focus on specific programmatic components, supported by partnership-supported work to build in-country research capacity. DISCUSSION: Building on early successes, the work of the Rwanda PHIT Partnership approach to HSS has already seen noticeable increases in facility capacity and quality of care. The rigorous planned evaluation of the Partnership's HSS activities will contribute to global knowledge about intervention methodology, cost, and population health impact.


Assuntos
Redes Comunitárias , Prestação Integrada de Cuidados de Saúde/normas , Melhoria de Qualidade/organização & administração , Adolescente , Adulto , Prestação Integrada de Cuidados de Saúde/economia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Avaliação de Resultados em Cuidados de Saúde , Desenvolvimento de Programas , Serviços de Saúde Rural , Ruanda , Adulto Jovem
4.
JACC Heart Fail ; 1(3): 230-6, 2013 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24621875

RESUMO

OBJECTIVES: This study sought to describe a decentralized strategy for heart failure diagnosis and management and report the clinical epidemiology at district hospitals in rural Rwanda. BACKGROUND: Heart failure contributes significantly to noncommunicable disease burden in sub-Saharan Africa. Specialized care is provided primarily at referral hospitals by physicians, limiting patients' access. Simplifying clinical strategies can facilitate decentralization of quality care to the district hospital level and improve care delivery. METHODS: Heart failure services were established within integrated advanced noncommunicable disease clinics in 2 rural district hospitals in Rwanda. Nurses, supervised by physicians, were trained to use simplified diagnostic and treatment algorithms including echocardiography with diagnoses confirmed by a cardiologist. Data on 192 heart failure patients treated between November 2006 and March 2011 were reviewed from an electronic medical record. RESULTS: In our study population, the median age was 35 years, 70% were women, 63% were subsistence farmers, and 6% smoked tobacco. At entry, 47% had New York Heart Association class III or IV functional status. Of children age <18 years (n = 54), rheumatic heart disease (48%), congenital heart disease (39%), and dilated cardiomyopathy (9%) were the leading diagnoses. Among adults (n = 138), dilated cardiomyopathy (54%), rheumatic heart disease (25%), and hypertensive heart disease (8%) were most common. During follow-up, 62% were retained in care, whereas 9% died and 29% were lost to follow-up. CONCLUSIONS: In rural Rwanda, the causes of heart failure are almost exclusively nonischemic even though patients often present with advanced symptoms. Training nurses, supervised by physicians, in simplified protocols and basic echocardiography is 1 approach to integrated, decentralized care for this vulnerable population.


Assuntos
Insuficiência Cardíaca/diagnóstico por imagem , Insuficiência Cardíaca/terapia , Adulto , África Subsaariana , Árvores de Decisões , Prestação Integrada de Cuidados de Saúde , Ecocardiografia/métodos , Feminino , Hospitais de Distrito , Humanos , Masculino , Ruanda
6.
Lancet ; 363(9407): 474-81, 2004 Feb 07.
Artigo em Inglês | MEDLINE | ID: mdl-14962530

RESUMO

Multidrug-resistant tuberculosis (MDR-TB) presents an increasing threat to global tuberculosis control. Many crucial management issues in MDR-TB treatment remain unanswered. We reviewed the existing scientific research on MDR-TB treatment, which consists entirely of retrospective cohort studies. Although direct comparisons of these studies are impossible, some insights can be gained: MDR-TB can and should be addressed therapeutically in resource-poor settings; starting of treatment early is crucial; aggressive treatment regimens and high-end dosing are recommended given the lower potency of second-line antituberculosis drugs; and strategies to improve treatment adherence, such as directly observed therapy, should be used. Opportunities to treat MDR-TB in developing countries are now possible through the Global Fund to Fight AIDS, TB, and Malaria, and the Green Light Committee for Access to Second-line Anti-tuberculosis Drugs. As treatment of MDR-TB becomes increasingly available in resource-poor areas, where it is needed most, further clinical and operational research is urgently needed to guide clinicians in the management of this disease.


Assuntos
Antituberculosos/uso terapêutico , Tuberculose Resistente a Múltiplos Medicamentos/tratamento farmacológico , Tuberculose Pulmonar/tratamento farmacológico , Antibióticos Antituberculose/uso terapêutico , Protocolos Clínicos , Estudos de Coortes , Farmacorresistência Bacteriana Múltipla , Quimioterapia Combinada , Saúde Global , Humanos , Programas Nacionais de Saúde , Estudos Retrospectivos , Resultado do Tratamento , Tuberculose Resistente a Múltiplos Medicamentos/prevenção & controle
7.
In. Hochman, Gilberto; Armus, Diego. Cuidar, controlar, curar: ensaios históricos sobre saúde e doença na América Latina e Caribe. Rio de Janeiro, Fiocruz, 2004. p.535-567, ilus.
Monografia em Português | HISA | ID: his-9369

RESUMO

O que se segue é uma etnografia processual do advento da Aids na pequena aldeia de Do Kay, no Haiti. Tenta examinar os problemas próprios de um estudo do significado cultural no período em que este começa a tomar forma - no caso presente, o significado e a descriçäo de uma nova doença. (AU)


Assuntos
História da Medicina , Síndrome da Imunodeficiência Adquirida/história , Haiti , Bruxaria
8.
In. Hochman, Gilberto; Armus, Diego. Cuidar, controlar, curar: ensaios históricos sobre saúde e doença na América Latina e Caribe. Rio de Janeiro, Fiocruz, 2004. p.535-567, ilus.
Monografia em Português | LILACS | ID: lil-386774

RESUMO

O que se segue é uma etnografia processual do advento da Aids na pequena aldeia de Do Kay, no Haiti. Tenta examinar os problemas próprios de um estudo do significado cultural no período em que este começa a tomar forma - no caso presente, o significado e a descrição de uma nova doença.


Assuntos
História da Medicina , Síndrome da Imunodeficiência Adquirida/história , Haiti , Bruxaria
9.
Clin Infect Dis ; 36(8): 996-1003, 2003 Apr 15.
Artigo em Inglês | MEDLINE | ID: mdl-12684912

RESUMO

Multidrug-resistant tuberculosis (MDR-TB) is a global public health problem affecting women of childbearing age. Little is known, however, about the safety of the drugs used to treat MDR-TB during pregnancy. We describe 7 patients who were treated for MDR-TB during pregnancy. These patients had chronic tuberculosis that had caused extensive parenchymal damage and had high-grade resistance to antituberculous drugs. All patients received individualized antituberculous therapy prior to delivery of healthy term infants. Neither obstetrical complications nor perinatal transmission of MDB-TB was observed. One patient experienced treatment failure, and another abandoned therapy. The other 5 patients are currently cured or in treatment and have culture-negative status. In each of these 7 cases, excellent treatment outcomes were obtained for the women and their children. Under certain circumstances, MDR-TB can be successfully treated during pregnancy.


Assuntos
Antituberculosos/uso terapêutico , Resistência a Múltiplos Medicamentos , Complicações Infecciosas na Gravidez/tratamento farmacológico , Tuberculose/tratamento farmacológico , Adulto , Feminino , Humanos , Testes de Sensibilidade Microbiana , Mycobacterium tuberculosis/efeitos dos fármacos , Gravidez , Resultado do Tratamento
10.
N Engl J Med ; 348(2): 119-28, 2003 Jan 09.
Artigo em Inglês | MEDLINE | ID: mdl-12519922

RESUMO

BACKGROUND: Despite the prevalence of multidrug-resistant tuberculosis in nearly all low-income countries surveyed, effective therapy has been deemed too expensive and considered not to be feasible outside referral centers. We evaluated the results of community-based therapy for multidrug-resistant tuberculosis in a poor section of Lima, Peru. METHODS: We describe the first 75 patients to receive ambulatory treatment with individualized regimens for chronic multidrug-resistant tuberculosis in northern Lima. We conducted a retrospective review of the charts of all patients enrolled in the program between August 1, 1996, and February 1, 1999, and identified predictors of poor outcomes. RESULTS: The infecting strains of Mycobacterium tuberculosis were resistant to a median of six drugs. Among the 66 patients who completed four or more months of therapy, 83 percent (55) were probably cured at the completion of treatment. Five of these 66 patients (8 percent) died while receiving therapy. Only one patient continued to have positive cultures after six months of treatment. All patients in whom treatment failed or who died had extensive bilateral pulmonary disease. In a multiple Cox proportional-hazards regression model, the predictors of the time to treatment failure or death were a low hematocrit (hazard ratio, 4.09; 95 percent confidence interval, 1.35 to 12.36) and a low body-mass index (hazard ratio, 3.23; 95 percent confidence interval, 0.90 to 11.53). Inclusion of pyrazinamide and ethambutol in the regimen (when susceptibility was confirmed) was associated with a favorable outcome (hazard ratio for treatment failure or death, 0.30; 95 percent confidence interval, 0.11 to 0.83). CONCLUSIONS: Community-based outpatient treatment of multidrug-resistant tuberculosis can yield high cure rates even in resource-poor settings. Early initiation of appropriate therapy can preserve susceptibility to first-line drugs and improve treatment outcomes.


Assuntos
Antituberculosos/uso terapêutico , Serviços de Saúde Comunitária , Terapia Diretamente Observada , Tuberculose Resistente a Múltiplos Medicamentos/tratamento farmacológico , Adulto , Assistência Ambulatorial , Países em Desenvolvimento , Feminino , Humanos , Masculino , Testes de Sensibilidade Microbiana , Peru , Modelos de Riscos Proporcionais , Estudos Retrospectivos , Resultado do Tratamento , Tuberculose Resistente a Múltiplos Medicamentos/microbiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA